INTCO MEDICAL(SZ:300677) Xin Lang Cai Jing·2026-01-19 01:36Core Viewpoint - In recent trading, Yingke Medical experienced a decline of 2.17% with a transaction volume of 517 million yuan, indicating a negative sentiment in the market [1] Financing and Margin Trading - On January 16, Yingke Medical had a financing buy amount of 47.01 million yuan and a financing repayment of 65.46 million yuan, resulting in a net financing outflow of 18.45 million yuan [1] - The total margin trading balance for Yingke Medical as of January 16 is 571 million yuan, with a financing balance of 559 million yuan, representing 2.10% of the circulating market value, which is below the 20th percentile level over the past year [1] - In terms of securities lending, 3,500 shares were repaid and 8,400 shares were sold on January 16, with a selling amount of 348,500 yuan, while the securities lending balance is 11.55 million yuan, exceeding the 80th percentile level over the past year [1] Financial Performance - For the period from January to September 2025, Yingke Medical achieved an operating income of 7.425 billion yuan, reflecting a year-on-year growth of 4.60%, and a net profit attributable to shareholders of 924 million yuan, which is a 34.47% increase year-on-year [2] Shareholder Information - As of September 30, 2025, Yingke Medical had 47,300 shareholders, a decrease of 21.11% from the previous period, while the average number of circulating shares per person increased by 25.65% to 9,832 shares [2] - The top ten circulating shareholders include notable entities such as Huabao Zhongzheng Medical ETF and E Fund Growth Enterprise ETF, with some shareholders reducing their holdings while others increased or newly entered [4] Dividend Distribution - Yingke Medical has distributed a total of 1.903 billion yuan in dividends since its A-share listing, with 245 million yuan distributed over the past three years [3]